Screener
Lexicon Pharmaceuticals LXRX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Assets | As of June 30, 2026 / (unaudited) | As of December 31, 2025 |
|---|---|---|
| Total liabilities | 75,535 | 77,449 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ Equity: | ||
| Convertible preferred stock, $0.01 par value; 5,000,000 shares authorized2,712,582 and 2,304,147 shares issued at June 30, 2026 and December 31, 2025, respectively; none outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; 900,000,000 shares authorized at June 30, 2026; 446,870,629 and 365,848,216 shares issued, respectively | 447 | 366 |
| Additional paid-in capital | 2,227,526 | 2,129,912 |
| Accumulated deficit | (2,050,401) | (2,017,583) |
| Accumulated other comprehensive (loss) income | (204) | 30 |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's preferred stock, shares authorized?
- Lexicon Pharmaceuticals (LXRX) reported preferred stock, shares authorized of $5B in Q2 2026.
- How has Lexicon Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- Lexicon Pharmaceuticals's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5B to $5B.
- What is the long-term trend for Lexicon Pharmaceuticals's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's preferred stock, shares authorized has grown at a 298.1% compound annual growth rate (CAGR), from $5M to $5B.
- What does preferred stock, shares authorized mean?
- Preferred Stock, Shares Authorized
Ask your AI about Lexicon Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude